| Product Code: ETC7053369 | Publication Date: Sep 2024 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Egypt Pharmacogenetic Testing Market Overview |
3.1 Egypt Country Macro Economic Indicators |
3.2 Egypt Pharmacogenetic Testing Market Revenues & Volume, 2021 & 2031F |
3.3 Egypt Pharmacogenetic Testing Market - Industry Life Cycle |
3.4 Egypt Pharmacogenetic Testing Market - Porter's Five Forces |
3.5 Egypt Pharmacogenetic Testing Market Revenues & Volume Share, By Type, 2021 & 2031F |
3.6 Egypt Pharmacogenetic Testing Market Revenues & Volume Share, By Gene Type, 2021 & 2031F |
3.7 Egypt Pharmacogenetic Testing Market Revenues & Volume Share, By Drug Type, 2021 & 2031F |
3.8 Egypt Pharmacogenetic Testing Market Revenues & Volume Share, By Sample, 2021 & 2031F |
3.9 Egypt Pharmacogenetic Testing Market Revenues & Volume Share, By Therapeutic Area, 2021 & 2031F |
3.10 Egypt Pharmacogenetic Testing Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.11 Egypt Pharmacogenetic Testing Market Revenues & Volume Share, By End User, 2021 & 2031F |
4 Egypt Pharmacogenetic Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing focus on personalized medicine and precision healthcare in Egypt. |
4.2.2 Growing awareness and acceptance of pharmacogenetic testing among healthcare professionals and patients. |
4.2.3 Government initiatives and policies promoting the adoption of advanced healthcare technologies in the country. |
4.3 Market Restraints |
4.3.1 Limited reimbursement policies for pharmacogenetic testing services in Egypt. |
4.3.2 Lack of trained healthcare professionals proficient in interpreting pharmacogenetic test results. |
4.3.3 High initial costs associated with setting up pharmacogenetic testing facilities and acquiring necessary equipment. |
5 Egypt Pharmacogenetic Testing Market Trends |
6 Egypt Pharmacogenetic Testing Market, By Types |
6.1 Egypt Pharmacogenetic Testing Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Type, 2021- 2031F |
6.1.3 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Whole Genome Sequencing, 2021- 2031F |
6.1.4 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Whole Exome Sequencing, 2021- 2031F |
6.1.5 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Array-Based Tests, 2021- 2031F |
6.1.6 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Single Gene Tests, 2021- 2031F |
6.2 Egypt Pharmacogenetic Testing Market, By Gene Type |
6.2.1 Overview and Analysis |
6.2.2 Egypt Pharmacogenetic Testing Market Revenues & Volume, By CYP2C19, 2021- 2031F |
6.2.3 Egypt Pharmacogenetic Testing Market Revenues & Volume, By CYP2D6, 2021- 2031F |
6.2.4 Egypt Pharmacogenetic Testing Market Revenues & Volume, By CYP2C9 and VKORC1, 2021- 2031F |
6.2.5 Egypt Pharmacogenetic Testing Market Revenues & Volume, By CYP1A2, 2021- 2031F |
6.2.6 Egypt Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*1502, 2021- 2031F |
6.2.7 Egypt Pharmacogenetic Testing Market Revenues & Volume, By HLA-B*5701, 2021- 2031F |
6.3 Egypt Pharmacogenetic Testing Market, By Drug Type |
6.3.1 Overview and Analysis |
6.3.2 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Prescription Drugs, 2021- 2031F |
6.3.3 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Nutraceuticals, 2021- 2031F |
6.3.4 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Recreational Drugs, 2021- 2031F |
6.3.5 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Herbal Supplements, 2021- 2031F |
6.3.6 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Vitamins, 2021- 2031F |
6.3.7 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Over-the-Counter Medications, 2021- 2031F |
6.4 Egypt Pharmacogenetic Testing Market, By Sample |
6.4.1 Overview and Analysis |
6.4.2 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Blood, 2021- 2031F |
6.4.3 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Saliva, 2021- 2031F |
6.5 Egypt Pharmacogenetic Testing Market, By Therapeutic Area |
6.5.1 Overview and Analysis |
6.5.2 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Cardiology, 2021- 2031F |
6.5.3 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Gastroenterology, 2021- 2031F |
6.5.4 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Anesthesiology, 2021- 2031F |
6.5.5 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Genomics, 2021- 2031F |
6.5.6 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Endocrinology, 2021- 2031F |
6.5.7 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Immunology & Hypersensitivity, 2021- 2031F |
6.5.8 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.5.9 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.6 Egypt Pharmacogenetic Testing Market, By Application |
6.6.1 Overview and Analysis |
6.6.2 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Clinical Practice, 2021- 2031F |
6.6.3 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Drug Development, 2021- 2031F |
6.6.4 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Drug Regulation, 2021- 2031F |
6.7 Egypt Pharmacogenetic Testing Market, By End User |
6.7.1 Overview and Analysis |
6.7.2 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Healthcare Providers, 2021- 2031F |
6.7.3 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Pharmaceutical & Biotechnology Companies, 2021- 2031F |
6.7.4 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
6.7.5 Egypt Pharmacogenetic Testing Market Revenues & Volume, By Others, 2021- 2031F |
7 Egypt Pharmacogenetic Testing Market Import-Export Trade Statistics |
7.1 Egypt Pharmacogenetic Testing Market Export to Major Countries |
7.2 Egypt Pharmacogenetic Testing Market Imports from Major Countries |
8 Egypt Pharmacogenetic Testing Market Key Performance Indicators |
8.1 Percentage increase in the number of healthcare facilities offering pharmacogenetic testing services. |
8.2 Number of research studies or clinical trials utilizing pharmacogenetic testing in Egypt. |
8.3 Rate of adoption of pharmacogenetic testing by healthcare providers in different specialties. |
9 Egypt Pharmacogenetic Testing Market - Opportunity Assessment |
9.1 Egypt Pharmacogenetic Testing Market Opportunity Assessment, By Type, 2021 & 2031F |
9.2 Egypt Pharmacogenetic Testing Market Opportunity Assessment, By Gene Type, 2021 & 2031F |
9.3 Egypt Pharmacogenetic Testing Market Opportunity Assessment, By Drug Type, 2021 & 2031F |
9.4 Egypt Pharmacogenetic Testing Market Opportunity Assessment, By Sample, 2021 & 2031F |
9.5 Egypt Pharmacogenetic Testing Market Opportunity Assessment, By Therapeutic Area, 2021 & 2031F |
9.6 Egypt Pharmacogenetic Testing Market Opportunity Assessment, By Application, 2021 & 2031F |
9.7 Egypt Pharmacogenetic Testing Market Opportunity Assessment, By End User, 2021 & 2031F |
10 Egypt Pharmacogenetic Testing Market - Competitive Landscape |
10.1 Egypt Pharmacogenetic Testing Market Revenue Share, By Companies, 2024 |
10.2 Egypt Pharmacogenetic Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here